NEW YORK, March 27, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of WellCare Health Plans, Inc. (NYSE: WCG) on behalf of stockholders concerning the proposed acquisition of the company by Centene Corporation (NYSE: CNC).
Click here to participate in the action.
Pursuant to the proposed transaction, announced on March 27, 2019 and valued at $17.3 billion, WellCare stockholders will receive $120.00 in cash and 3.38 shares of Centene for each share of WellCare common stock owned. The investigation focuses on whether WellCare and its board of directors violated the federal securities laws and/or breached their fiduciary duties to the Company’s stockholders by failing to conduct a fair process and whether and by how much the proposed transaction undervalues the Company.
If you own WellCare shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at email@example.com, or telephone at (212) 308-1869, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation of WellCare please go to https://bespc.com/wcg/. For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.